Urban lymphatic filariasis

被引:0
|
作者
Paul E. Simonsen
Mbutolwe E. Mwakitalu
机构
[1] University of Copenhagen,DBL–Centre for Health Research and Development, Faculty of Health and Medical Sciences
[2] National Institute for Medical Research,undefined
来源
Parasitology Research | 2013年 / 112卷
关键词
Lymphatic Filariasis; Mass Drug Administration; Infective Larva; Hydrocele; Slum Area;
D O I
暂无
中图分类号
学科分类号
摘要
Lymphatic filariasis (LF) is a disabling and disfiguring disease resulting from a mosquito-borne parasitic infection. It is a major public health problem in many countries with a warm climate. Research and control activities have mainly focused on LF in rural areas where it also has its major impact. However, with rapid and unplanned growth of cities in the developing world, there is a need also to consider LF transmission and control in urban settings. Here, we review currently available knowledge on urban LF and the environmental and socio-economic basis for its occurrence. Among the three parasite species causing LF in humans, only Wuchereria bancrofti has been documented to have a significant potential for urban transmission. This is primarily because one of its vectors, Culex quinquefasciatus, thrives and proliferates excessively in crowded city areas with poor sanitary, sewerage and drainage facilities. For this reason, urban LF also often shows a marked focality in distribution, with most cases clustered in areas inhabited by the less privileged city populations. More knowledge on urban LF is needed, in particular on its socio-economic and human behavioural context, on the potential for transmission in regions where other LF vector species predominate, and on rapid methods for identification and mapping of risk areas, to provide a strong evidence base for its control.
引用
收藏
页码:35 / 44
页数:9
相关论文
共 50 条
  • [21] Eliminating Lymphatic Filariasis: Is it Worth it?
    Niessen, Louis Wilhelmus
    Taylor, Mark L.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (12) : 2568 - 2569
  • [22] Cytomorphologic profile of lymphatic filariasis
    Arora, VK
    Singh, N
    Bhatia, A
    ACTA CYTOLOGICA, 1996, 40 (05) : 948 - 952
  • [23] Lymphatic filariasis and the women of India
    Bandyopadhyay, L
    SOCIAL SCIENCE & MEDICINE, 1996, 42 (10) : 1401 - 1410
  • [24] Ivermectin: effectiveness in lymphatic filariasis
    Brown, KR
    Ricci, FM
    Ottesen, EA
    PARASITOLOGY, 2000, 121 : S133 - S146
  • [25] Lymphatic filariasis on the coast of Ghana
    Dunyo, SK
    Appawu, M
    Nkrumah, FK
    BaffoeWilmot, A
    Pedersen, EM
    Simonsen, PE
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (06) : 634 - 638
  • [26] Seroprevalence of lymphatic filariasis at Puducherry
    Parija S.C.
    Garg A.
    Journal of Parasitic Diseases, 2010, 34 (1) : 20 - 23
  • [27] AN OVERVIEW OF LYMPHATIC FILARIASIS LYMPHEDEMA
    Rajasekaran, S.
    Anuradha, R.
    Manokaran, G.
    Bethunaickan, R.
    LYMPHOLOGY, 2017, 50 (04) : 164 - 182
  • [28] Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
    Banerjee, Sitikantha
    Bandyopadhyay, Kajari
    Khan, Mubashshera F.
    Akkilagunta, Sujiv
    Selvaraj, Kalaiselvi
    Tripathy, Jaya P.
    Solanki, Ranjan
    Kushwaha, Arvind S.
    Deshmukh, Pradeep
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (09) : 3009 - 3014
  • [29] Albendazole for the control and elimination of lymphatic filariasis: systematic review
    Critchley, J
    Addiss, D
    Ejere, H
    Gamble, C
    Garner, P
    Gelband, H
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2005, 10 (09) : 818 - 825
  • [30] Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope
    Masiyiwa, Tsitsi
    Bockarie, Moses John
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 140 : 102 - 103